Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Taita Chemical Company, Limited (1309.TW)
Taipei, TW
Taita Chemical Company, Limited, established in 1960 and based in Taipei, Taiwan, is a prominent manufacturer and distributor of styrenic polymers. The company's market footprint spans Taiwan, Mainland China, Hong Kong, and the United States. Its primary product offerings include TAITALAC brand acrylonitrile-butadiene-styrene (ABS) resin, a versatile terpolymer plastic. Taita Chemical also produces general purpose and high impact polystyrene under the TAITAREX brand, which are widely employed in the creation of food containers, CD cases, stationery, toys, insulation boards, business machinery, various electronic and electrical appliances, and a range of consumer goods. Additionally, the company supplies TAITACELL brand expandable polystyrene resins. Beyond its core plastics business, Taita Chemical also provides glass wool materials. The firm offers a specialized service in cubic printing, a technique used for applying ornamental finishes to three-dimensional items. This service is utilized across diverse sectors, including automotive components, home electronic devices, IT products, interior decor, sporting equipment, and promotional articles. The company actively participates in international export activities to support its global distribution.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.60% | -5.97% | -26.77% | +35.66% | +49.77% | +48.43% | +33.47% | -15.56% | -51.66% | +174.92% | +20.80% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-22.2% Q1'26: -21.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-91.1% Q1'26: -278.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+4.5% Q1'26: +5.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-2.9% Q1'26: -8.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-9.1% Q1'26: -19.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.9% Q1'26: +3.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-7.46× Q1'26: -1.42× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
17.03B
est: 18.95B (-10.1%)
|
16.42B
est: 16.29B (+0.8%)
|
19.82B
est: 19.86B (-0.2%)
|
21.68B
est: 22.37B (-3.1%)
|
17.67B
est: 17.67B (+0.0%)
|
15.50B
est: 15.41B (+0.6%)
|
20.77B
est: 20.64B (+0.6%)
|
18.08B
est: 17.98B (+0.6%)
|
15.21B
est: 16.78B (-9.4%)
|
18.62B
est: 18.67B (-0.2%)
|
14.49B
est: 14.62B (-0.9%)
|
14.10B
14.10B – 14.10B
-3.6% YoY
|
13.18B
13.18B – 13.18B
-6.5% YoY
|
| EBITDA |
386.64M
est: 1.26B (-69.2%)
|
437.91M
est: 1.08B (-59.5%)
|
912.72M
est: 1.32B (-30.7%)
|
575.12M
est: 1.48B (-61.2%)
|
819.29M
est: 1.17B (-30.1%)
|
2.63B
est: 1.02B (+157.0%)
|
2.61B
est: 1.37B (+90.9%)
|
762.07M
est: 1.19B (-36.1%)
|
-110.76M
est: 495.58M (-122.3%)
|
27.29M
est: 551.46M (-95.1%)
|
-209.65M
est: 431.87M (-148.5%)
|
416.46M
416.46M – 416.46M
-3.6% YoY
|
389.25M
389.25M – 389.25M
-6.5% YoY
|
| EBIT |
145.30M
est: 1.03B (-85.9%)
|
231.43M
est: 884.24M (-73.8%)
|
675.95M
est: 1.08B (-37.3%)
|
277.62M
est: 1.21B (-77.1%)
|
609.30M
est: 959.15M (-36.5%)
|
2.42B
est: 836.47M (+189.5%)
|
2.41B
est: 1.12B (+115.3%)
|
551.21M
est: 975.81M (-43.5%)
|
-326.16M
est: 288.28M (-213.1%)
|
-188.84M
est: 320.78M (-158.9%)
|
-423.68M
est: 251.22M (-268.7%)
|
242.25M
242.25M – 242.25M
-3.6% YoY
|
226.43M
226.43M – 226.43M
-6.5% YoY
|
| Net Income |
67.53M
est: -16.31M (+514.0%)
|
120.88M
est: 161.49M (-25.1%)
|
502.08M
est: 396.38M (+26.7%)
|
207.97M
est: 433.90M (-52.1%)
|
397.98M
est: 284.52M (+39.9%)
|
1.92B
est: 1.81B (+5.8%)
|
1.85B
est: 1.74B (+6.4%)
|
412.08M
est: 499.60M (-17.5%)
|
-273.54M
est: -327.84M (+16.6%)
|
-223.01M
est: -221.67M (-0.6%)
|
-427.37M
est: -427.37M (+0.0%)
|
-113.17M
-113.17M – -113.17M
+73.5% YoY
|
-43.94M
-43.94M – -43.94M
+61.2% YoY
|
| SGA |
707.94M
est: 1.16B (-38.8%)
|
695.35M
est: 993.70M (-30.0%)
|
736.47M
est: 1.21B (-39.2%)
|
743.05M
est: 1.36B (-45.6%)
|
706.35M
est: 1.08B (-34.5%)
|
681.29M
est: 940.02M (-27.5%)
|
1.12B
est: 1.26B (-11.0%)
|
1.52B
est: 1.10B (+38.3%)
|
885.99M
est: 1.11B (-19.9%)
|
1.21B
est: 1.23B (-1.8%)
|
996.62M
est: 964.43M (+3.3%)
|
930.03M
930.03M – 930.03M
-3.6% YoY
|
869.27M
869.27M – 869.27M
-6.5% YoY
|
| EPS |
0.17
est: -0.04 (+512.6%)
|
0.30
est: 0.41 (-26.5%)
|
1.26
est: 1.00 (+25.8%)
|
0.52
est: 1.10 (-52.6%)
|
1.00
est: 0.72 (+39.1%)
|
4.83
est: 4.58 (+5.4%)
|
4.65
est: 4.39 (+5.9%)
|
1.04
est: 1.26 (-17.6%)
|
-0.69
est: -0.82 (+15.9%)
|
-0.56
est: -0.56 (-0.9%)
|
-1.07
est: -1.08 (+0.9%)
|
-0.28
-0.28 – -0.28
+73.8% YoY
|
-0.11
-0.11 – -0.11
+61.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 89.2K | 0.65% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 13.5K | 0.42% |
| 3 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.00% | 7.1K | 0.35% |
| 4 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 13.7K | 0.44% |
| 5 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 169.2K | 0.39% |
| 6 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 121.0K | 0.29% |
| 7 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.00% | 2.7K | 0.56% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 86.3K | 0.28% |
| 9 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.00% | 469.37 | 0.33% |
| 10 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 50.3K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yen Tai-Ming | Senior Vice President | 4M | male |
| Pei-Chi Wu | President, GM & Director | 4M | male |
| Yi-Gui Wu | Chairman & Chief Executive Officer | 4M | male |
| Chun-Hao Huang | Senior Manager | 3M | male |
| Wen-Yao Wang | Director of Cianjhen Plant | 3M | male |
| Kuo-Yun Liao | Head of the Toufen Plant | 2M | male |
| Fei-Yun Lo | Head of Finance Department | — | female |
| Chunyao Li | Head of Accounting Department & Accounting Supervisor | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1309.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
